Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 62 of 1714:
52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72
Gene Compound Assay Inh Ic50 Ki View
glutamate receptor, ionotropic, N-methyl D-aspartate 2A CLOTRIMAZOLE Glutamate, NMDA, Agonism 88% 13.064uM 11.82uM View
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) CLOTRIMAZOLE Glutamate, NMDA, Agonism 88% 13.064uM 11.82uM View
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B CLOTRIMAZOLE Glutamate, NMDA, Agonism 88% 13.064uM 11.82uM View
5-hydroxytryptamine (serotonin) receptor 2C CLOTRIMAZOLE Serotonin 5-HT2C 88% 14.472uM 7.581uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 AMIODARONE Adrenergic, Norepinephrine Transporter 88% 2.271uM 2.252uM View
thromboxane A synthase 1 TAMOXIFEN Thromboxane Synthetase 88% .916uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) TAMOXIFEN Thromboxane Synthetase 88% .916uM NoneNone View
A3 adenosine receptor TAMOXIFEN Adenosine A3 88% 3.701uM 2.092uM View
calcium channel, voltage-dependent, gamma subunit 8 DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, gamma subunit 7 DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, gamma subunit 6 DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, gamma subunit 5 DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, gamma subunit 4 DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, gamma subunit 3 DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, gamma subunit 2 DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, gamma subunit 1 DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, beta 4 subunit DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, beta 3 subunit DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, beta 2 subunit DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, gamma subunit 5 CINNARIZINE Calcium Channel Type L, Benzothiazepine 87% .823uM .732uM View
calcium channel, voltage-dependent, gamma subunit 4 CINNARIZINE Calcium Channel Type L, Benzothiazepine 87% .823uM .732uM View
calcium channel, voltage-dependent, gamma subunit 3 CINNARIZINE Calcium Channel Type L, Benzothiazepine 87% .823uM .732uM View
calcium channel, voltage-dependent, gamma subunit 2 CINNARIZINE Calcium Channel Type L, Benzothiazepine 87% .823uM .732uM View
calcium channel, voltage-dependent, gamma subunit 1 CINNARIZINE Calcium Channel Type L, Benzothiazepine 87% .823uM .732uM View
calcium channel, voltage-dependent, beta 4 subunit CINNARIZINE Calcium Channel Type L, Benzothiazepine 87% .823uM .732uM View
calcium channel, voltage-dependent, beta 3 subunit CINNARIZINE Calcium Channel Type L, Benzothiazepine 87% .823uM .732uM View
calcium channel, voltage-dependent, beta 2 subunit CINNARIZINE Calcium Channel Type L, Benzothiazepine 87% .823uM .732uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit CINNARIZINE Calcium Channel Type L, Benzothiazepine 87% .823uM .732uM View
calcium channel, voltage-dependent, alpha 1F subunit CINNARIZINE Calcium Channel Type L, Benzothiazepine 87% .823uM .732uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit CINNARIZINE Calcium Channel Type L, Benzothiazepine 87% .823uM .732uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit CINNARIZINE Calcium Channel Type L, Benzothiazepine 87% .823uM .732uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit CINNARIZINE Calcium Channel Type L, Benzothiazepine 87% .823uM .732uM View
calcium channel, voltage-dependent, beta 1 subunit CINNARIZINE Calcium Channel Type L, Benzothiazepine 87% .823uM .732uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit CINNARIZINE Calcium Channel Type L, Benzothiazepine 87% .823uM .732uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit CINNARIZINE Calcium Channel Type L, Benzothiazepine 87% .823uM .732uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 CINNARIZINE Calcium Channel Type L, Benzothiazepine 87% .823uM .732uM View
cytochrome P450, family 3, subfamily a, polypeptide 13 PHENYLHYDRAZINE CYP450-3A4 Inhibition 87% .9uM NoneNone View
Cytochrom P450-2D6 monooxygenase PROPRANOLOL CYP450-2D6 Inhibition 87% 2uM NoneNone View
Cytochrom P450-2D6 monooxygenase LANSOPRAZOLE CYP450-2D6 Inhibition 87% 5.3148uM NoneNone View
arachidonate 15-lipoxygenase, second type VINBLASTINE Lipoxygenase 15-LO 87% 5.037uM NoneNone View
arachidonate 15-lipoxygenase VINBLASTINE Lipoxygenase 15-LO 87% 5.037uM NoneNone View
arachidonate 15-lipoxygenase VINBLASTINE Lipoxygenase 15-LO 87% 5.037uM NoneNone View
adrenergic receptor, beta 2 DOBUTAMINE Adrenergic beta2 87% 1.517uM 1.043uM View
adrenergic receptor, alpha 2a METHYLERGONOVINE Adrenergic alpha2A 87% 1.59uM .596uM View
adrenergic receptor, alpha 1d (Non-specific probe) CLONIDINE Adrenergic alpha1D 87% 1.21uM .595uM View
adrenergic receptor, alpha 1d (Non-specific probe) BUSPIRONE Adrenergic alpha1D 87% 1.077uM .529uM View
dopamine receptor D1A ERGOTAMINE Dopamine D1 87% 1.728uM .864uM View
histamine receptor H 1 PROMAZINE Histamine H1, Central 87% .003435uM .000399uM View
thromboxane A synthase 1 NELFINAVIR Thromboxane Synthetase 87% 21.11uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) NELFINAVIR Thromboxane Synthetase 87% 21.11uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 NELFINAVIR Calcium Channel Type L, Dihydropyridine 87% 9.84uM 6.324uM View
calcium channel, voltage-dependent, gamma subunit 4 NELFINAVIR Calcium Channel Type L, Dihydropyridine 87% 9.84uM 6.324uM View
calcium channel, voltage-dependent, gamma subunit 3 NELFINAVIR Calcium Channel Type L, Dihydropyridine 87% 9.84uM 6.324uM View
calcium channel, voltage-dependent, gamma subunit 2 NELFINAVIR Calcium Channel Type L, Dihydropyridine 87% 9.84uM 6.324uM View
calcium channel, voltage-dependent, gamma subunit 1 NELFINAVIR Calcium Channel Type L, Dihydropyridine 87% 9.84uM 6.324uM View
calcium channel, voltage-dependent, beta 4 subunit NELFINAVIR Calcium Channel Type L, Dihydropyridine 87% 9.84uM 6.324uM View
calcium channel, voltage-dependent, beta 3 subunit NELFINAVIR Calcium Channel Type L, Dihydropyridine 87% 9.84uM 6.324uM View
calcium channel, voltage-dependent, beta 2 subunit NELFINAVIR Calcium Channel Type L, Dihydropyridine 87% 9.84uM 6.324uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit NELFINAVIR Calcium Channel Type L, Dihydropyridine 87% 9.84uM 6.324uM View
calcium channel, voltage-dependent, alpha 1F subunit NELFINAVIR Calcium Channel Type L, Dihydropyridine 87% 9.84uM 6.324uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit NELFINAVIR Calcium Channel Type L, Dihydropyridine 87% 9.84uM 6.324uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit NELFINAVIR Calcium Channel Type L, Dihydropyridine 87% 9.84uM 6.324uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit NELFINAVIR Calcium Channel Type L, Dihydropyridine 87% 9.84uM 6.324uM View
calcium channel, voltage-dependent, beta 1 subunit NELFINAVIR Calcium Channel Type L, Dihydropyridine 87% 9.84uM 6.324uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit NELFINAVIR Calcium Channel Type L, Dihydropyridine 87% 9.84uM 6.324uM View
cholinergic receptor, muscarinic 1 CLOMIPHENE Muscarinic M1 86% 1.628uM .392uM View
calcium channel, voltage-dependent, gamma subunit 8 CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit TIRILAZAD Calcium Channel Type L, Phenylalkylamine 86% 2.496uM 2.427uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit TIRILAZAD Calcium Channel Type L, Phenylalkylamine 86% 2.496uM 2.427uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit TIRILAZAD Calcium Channel Type L, Phenylalkylamine 86% 2.496uM 2.427uM View
calcium channel, voltage-dependent, beta 1 subunit TIRILAZAD Calcium Channel Type L, Phenylalkylamine 86% 2.496uM 2.427uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit TIRILAZAD Calcium Channel Type L, Phenylalkylamine 86% 2.496uM 2.427uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit TIRILAZAD Calcium Channel Type L, Phenylalkylamine 86% 2.496uM 2.427uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 TIRILAZAD Calcium Channel Type L, Phenylalkylamine 86% 2.496uM 2.427uM View
opioid receptor, delta 1 PACLITAXEL Opiate delta 86% 4.202uM 1.481uM View
opioid receptor, sigma 1 AMITRIPTYLINE Sigma1 86% 1.031uM .433uM View
adrenergic receptor, alpha 2a AMOXAPINE Adrenergic alpha2A 86% 1.314uM .493uM View
calcium channel, voltage-dependent, gamma subunit 8 U-78517F Calcium Channel Type L, Dihydropyridine 86% 1.659uM 1.066uM View
calcium channel, voltage-dependent, gamma subunit 7 U-78517F Calcium Channel Type L, Dihydropyridine 86% 1.659uM 1.066uM View
calcium channel, voltage-dependent, gamma subunit 6 U-78517F Calcium Channel Type L, Dihydropyridine 86% 1.659uM 1.066uM View
calcium channel, voltage-dependent, gamma subunit 5 U-78517F Calcium Channel Type L, Dihydropyridine 86% 1.659uM 1.066uM View
calcium channel, voltage-dependent, gamma subunit 4 U-78517F Calcium Channel Type L, Dihydropyridine 86% 1.659uM 1.066uM View
calcium channel, voltage-dependent, gamma subunit 3 U-78517F Calcium Channel Type L, Dihydropyridine 86% 1.659uM 1.066uM View
calcium channel, voltage-dependent, gamma subunit 2 U-78517F Calcium Channel Type L, Dihydropyridine 86% 1.659uM 1.066uM View
calcium channel, voltage-dependent, gamma subunit 1 U-78517F Calcium Channel Type L, Dihydropyridine 86% 1.659uM 1.066uM View
calcium channel, voltage-dependent, beta 4 subunit U-78517F Calcium Channel Type L, Dihydropyridine 86% 1.659uM 1.066uM View
calcium channel, voltage-dependent, beta 3 subunit U-78517F Calcium Channel Type L, Dihydropyridine 86% 1.659uM 1.066uM View
calcium channel, voltage-dependent, beta 2 subunit U-78517F Calcium Channel Type L, Dihydropyridine 86% 1.659uM 1.066uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit U-78517F Calcium Channel Type L, Dihydropyridine 86% 1.659uM 1.066uM View
calcium channel, voltage-dependent, alpha 1F subunit U-78517F Calcium Channel Type L, Dihydropyridine 86% 1.659uM 1.066uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit U-78517F Calcium Channel Type L, Dihydropyridine 86% 1.659uM 1.066uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit U-78517F Calcium Channel Type L, Dihydropyridine 86% 1.659uM 1.066uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit U-78517F Calcium Channel Type L, Dihydropyridine 86% 1.659uM 1.066uM View
5-hydroxytryptamine (serotonin) receptor 1A BW-723C86 Serotonin 5-HT1A 86% 1.1278uM .6445uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 BUPROPION Dopamine Transporter 86% 1.0338uM .8214uM View
tachykinin receptor 2 4-NONYLPHENOL Tachykinin NK2 86% 4.514uM 1.505uM View
sodium channel, voltage-gated, type IV, beta THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel associated protein 1 THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel associated protein 2 THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type III, beta THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type I, alpha THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type IX, alpha THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type VII, alpha THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
amiloride-sensitive cation channel 5, intestinal THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type III, beta THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type XI, alpha THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type I, beta THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type 10, alpha polypeptide THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type IV, alpha polypeptide THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type V, alpha polypeptide THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type II, beta THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, nonvoltage-gated 1 alpha THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, nonvoltage-gated 1 gamma THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, nonvoltage-gated 1 beta THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
calcium channel, voltage-dependent, beta 4 subunit FLUPHENAZINE Calcium Channel Type L, Phenylalkylamine 89% 2.534uM 2.464uM View
calcium channel, voltage-dependent, beta 3 subunit FLUPHENAZINE Calcium Channel Type L, Phenylalkylamine 89% 2.534uM 2.464uM View
calcium channel, voltage-dependent, beta 2 subunit FLUPHENAZINE Calcium Channel Type L, Phenylalkylamine 89% 2.534uM 2.464uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit FLUPHENAZINE Calcium Channel Type L, Phenylalkylamine 89% 2.534uM 2.464uM View
calcium channel, voltage-dependent, alpha 1F subunit FLUPHENAZINE Calcium Channel Type L, Phenylalkylamine 89% 2.534uM 2.464uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit FLUPHENAZINE Calcium Channel Type L, Phenylalkylamine 89% 2.534uM 2.464uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit FLUPHENAZINE Calcium Channel Type L, Phenylalkylamine 89% 2.534uM 2.464uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit FLUPHENAZINE Calcium Channel Type L, Phenylalkylamine 89% 2.534uM 2.464uM View
calcium channel, voltage-dependent, beta 1 subunit FLUPHENAZINE Calcium Channel Type L, Phenylalkylamine 89% 2.534uM 2.464uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit FLUPHENAZINE Calcium Channel Type L, Phenylalkylamine 89% 2.534uM 2.464uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit FLUPHENAZINE Calcium Channel Type L, Phenylalkylamine 89% 2.534uM 2.464uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 FLUPHENAZINE Calcium Channel Type L, Phenylalkylamine 89% 2.534uM 2.464uM View
adrenergic receptor, alpha 2a DOXEPIN Adrenergic alpha2A 89% 1.335uM .501uM View
histamine receptor H 2 HALOPERIDOL Histamine H2 89% 1.166uM 1.147uM View
adrenergic receptor, alpha 2b MONTELUKAST Adrenergic alpha2C 89% 5.279uM .767uM View
adrenergic receptor, alpha 2c (Non-specific probe) MONTELUKAST Adrenergic alpha2C 89% 5.279uM .767uM View
5-hydroxytryptamine (serotonin) receptor 2B CITALOPRAM Serotonin 5-HT2B 89% 1.839uM 1.171uM View
cholinergic receptor, muscarinic 3 MIANSERIN Muscarinic M3 89% 1.405uM .298uM View
cholinergic receptor, muscarinic 1 MIANSERIN Muscarinic M1 89% 1.423uM .343uM View
mitogen activated protein kinase 14 MC 258717 Protein Serine/Threonine Kinase, p38alpha 89% 2.272uM NoneNone View
mitogen-activated protein kinase 14 MC 258717 Protein Serine/Threonine Kinase, p38alpha 89% 2.272uM NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) 1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE CYP450-2C9 Inhibition 89% 2uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE CYP450-2C9 Inhibition 89% 2uM NoneNone View
adrenergic receptor, alpha 2a 1-NAPHTHYL ISOTHIOCYANATE Adrenergic alpha2A 89% 6.272uM 2.352uM View
cholinergic receptor, muscarinic 4 QUINACRINE Muscarinic M4 89% 1.983uM .277uM View
cholinergic receptor, muscarinic 4 KETOTIFEN Muscarinic M4 89% 1.009uM .141uM View
adrenergic receptor, alpha 2a SELEGILINE Adrenergic alpha2A 89% 1.798uM .674uM View
monoamine oxidase A NABUMETONE Monoamine Oxidase MAOA 89% .998uM NoneNone View
monoamine oxidase A NABUMETONE Monoamine Oxidase MAOA 89% .998uM NoneNone View
adrenergic receptor, alpha 2a NORTRIPTYLINE Adrenergic alpha2A 89% .732uM .275uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 OLANZAPINE Serotonin Transporter 89% 1.033uM .549uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 NORETHINDRONE Serotonin Transporter 89% 4.537uM 2.411uM View
5-hydroxytryptamine (serotonin) receptor 1A NORTRIPTYLINE Serotonin 5-HT1A 89% 1.868uM 1.068uM View
adrenergic receptor, alpha 2a OXYMETAZOLINE Imidazoline I2, Central 89% .027uM .018uM View
adrenergic receptor, alpha 2c (Non-specific probe) OXYMETAZOLINE Imidazoline I2, Central 89% .027uM .018uM View
dopamine receptor 2 EBASTINE Dopamine D2L 89% 1.1491uM .383uM View
A3 adenosine receptor EBASTINE Adenosine A3 89% 3.1953uM 1.8061uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 CHLORDIAZEPOXIDE GABAA, Benzodiazepine, Central 89% 1.429uM 1.164uM View
gamma-aminobutyric acid A receptor, gamma 1 CHLORDIAZEPOXIDE GABAA, Benzodiazepine, Central 89% 1.429uM 1.164uM View
gamma-aminobutyric acid A receptor, pi CHLORDIAZEPOXIDE GABAA, Benzodiazepine, Central 89% 1.429uM 1.164uM View
AT hook, DNA binding motif, containing 1 (DBSS) CHLORDIAZEPOXIDE GABAA, Benzodiazepine, Central 89% 1.429uM 1.164uM View
gamma-aminobutyric acid A receptor, theta CHLORDIAZEPOXIDE GABAA, Benzodiazepine, Central 89% 1.429uM 1.164uM View
gamma-aminobutyric acid A receptor, gamma 2 CHLORDIAZEPOXIDE GABAA, Benzodiazepine, Central 89% 1.429uM 1.164uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 CHLORDIAZEPOXIDE GABAA, Benzodiazepine, Central 89% 1.429uM 1.164uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 CHLORDIAZEPOXIDE GABAA, Benzodiazepine, Central 89% 1.429uM 1.164uM View
gamma-aminobutyric acid A receptor, alpha 2 CHLORDIAZEPOXIDE GABAA, Benzodiazepine, Central 89% 1.429uM 1.164uM View
gamma-aminobutyric acid A receptor, alpha 1 CHLORDIAZEPOXIDE GABAA, Benzodiazepine, Central 89% 1.429uM 1.164uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 CHLORDIAZEPOXIDE GABAA, Benzodiazepine, Central 89% 1.429uM 1.164uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 CHLORDIAZEPOXIDE GABAA, Benzodiazepine, Central 89% 1.429uM 1.164uM View
gamma-aminobutyric acid A receptor, delta CHLORDIAZEPOXIDE GABAA, Benzodiazepine, Central 89% 1.429uM 1.164uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, alpha 1F subunit DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, beta 1 subunit DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 DICYCLOMINE Calcium Channel Type L, Benzothiazepine 88% 1.736uM 1.543uM View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase CISAPRIDE HMG-CoA Reductase 88% 3.37uM NoneNone View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase CISAPRIDE HMG-CoA Reductase 88% 3.37uM NoneNone View
dopamine receptor 2 CISAPRIDE Dopamine D2L 88% .473uM .158uM View
dopamine receptor D1A CARVEDILOL Dopamine D1 88% 1.498uM .749uM View
adrenergic receptor, beta 3 TIMOLOL Adrenergic beta3 88% .452uM .339uM View
cholinergic receptor, muscarinic 5 FLUOXETINE Muscarinic M5 88% 1.358uM .976uM View
phosphodiesterase 3B CILOSTAZOL Phosphodiesterase PDE3 88% .271uM NoneNone View
phosphodiesterase 3A CILOSTAZOL Phosphodiesterase PDE3 88% .271uM NoneNone View
adrenergic receptor, alpha 2b TICLOPIDINE Adrenergic alpha2C 88% 1.175uM .171uM View
adrenergic receptor, alpha 2c (Non-specific probe) TICLOPIDINE Adrenergic alpha2C 88% 1.175uM .171uM View
A3 adenosine receptor SULINDAC SULFIDE Adenosine A3 88% 7.231uM 4.087uM View
prostaglandin-endoperoxide synthase 1 MONOBENZONE Cyclooxygenase COX-1 88% 1.019uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) MONOBENZONE Cyclooxygenase COX-1 88% 1.019uM NoneNone View
calcium channel, voltage-dependent, beta 4 subunit HALOPERIDOL Calcium Channel Type L, Phenylalkylamine 88% .552uM .536uM View
sodium channel, voltage-gated, type IX, alpha BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
adrenergic receptor, beta 1 LISURIDE Adrenergic beta1 88% .559uM .323uM View
adrenergic, beta-1-, receptor LISURIDE Adrenergic beta1 88% .559uM .323uM View
adrenergic receptor, alpha 2b MAPROTILINE Adrenergic alpha2C 88% 3.044uM .442uM View
adrenergic receptor, alpha 2c (Non-specific probe) MAPROTILINE Adrenergic alpha2C 88% 3.044uM .442uM View
dopamine receptor D1A IVERMECTIN Dopamine D1 88% 4.5148uM 2.2574uM View
5-hydroxytryptamine (serotonin) receptor 2C PYRILAMINE Serotonin 5-HT2C 88% 1.13uM .592uM View
mitogen activated protein kinase 14 VX-745 Protein Serine/Threonine Kinase, p38alpha 88% .643uM NoneNone View
mitogen-activated protein kinase 14 VX-745 Protein Serine/Threonine Kinase, p38alpha 88% .643uM NoneNone View
adrenergic receptor, alpha 1b ROXITHROMYCIN Adrenergic alpha1B 88% .989uM .548uM View
adenosine A2a receptor SILDENAFIL Adenosine A2A 88% .253uM .142uM View